In a report released today, Michael Binetti from Evercore ISI reiterated a Buy rating on Ferrari (RACE – Research Report), with a price ...
Evercore ISI analyst Liisa Bayko upgraded Editas Medicine (EDIT) to Outperform from In Line with a price target of $7, up from $3. Editas has ...
Property and casualty insurers, as well as life insurers, are expected to benefit from Donald Trump's presidential election ...
In this article, we are going to take a look at where GE Vernova Inc. (NYSE:GEV) stands against the other AI stocks that you ...
Proxies for former President Donald Trump's trade policies — specifically bitcoin and the Chinese yuan — can help gauge what market participants are making of the election results, Julian Emanuel, ...
The ride-hailing pioneer is contending with slowing bookings growth, rising insurance costs and an alliance between DoorDash ...